Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 June 2005 : Hypothesis  

The implantation of a permanent transvenous endocardial pacemaker in 42 dogs: a retrospective study

Oriol Domenech, Roberto Santilli, Danitza Pradelli, Claudio Bussadori

Med Sci Monit 2005; 11(6): BR168-175 :: ID: 16485


Background: The primary indication for pacemaker therapy in dogs and cats is symptomatic bradyarrhythmia that does not respond to medical treatment. Different techniques have been used for pacemaker implantation since 1968. Transvenous endocardial pacemaker implantation is a minimally invasive method and represents the fi rst choice of treatment for this type of arrhythmia.
Material/Methods: The authors reviewed retrospectively the indications, effi cacy, complications, and long-term outcome
in 42 cases of transvenous endocardial pacemaker implantation in dogs.
Results: Complications which required a second intervention occurred in 10 dogs (23.8%), while complications
that did not require another procedure occurred in 5 dogs (11.9%). Two of the 42 patients died due to the pacemaker implantation (mortality: 4.76%). The mean survival age of those patients
with a pacemaker that survived the procedure was 11.4 years.
Conclusions: The life expectancy of our patients carrying a pacemaker was higher than the general life expectancy published in a study on a large population of dogs. The low mortality rate and long life expectancy of dogs treated makes transvenous pacemaker implantation an effi cacious and safe alternative for treatment of those bradyarrhythmias that do not respond to medical therapy

Keywords: Bradycardia - therapy, Dermatitis, Atopic - complications, Bradycardia - therapy, Dermatitis, Atopic - complications, Dogs, Equipment Design, Pacemaker, Artificial - adverse effects, Physical Conditioning, Animal, Radiography, Thoracic, Seizures - etiology, Syncope - etiology, Time Factors

Add Comment 0 Comments

678 15


01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911

In Press

28 May 2023 : Database Analysis  

Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021

Med Sci Monit In Press; DOI: 10.12659/MSM.938715  

25 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

25 May 2023 : Review article  

A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drug...

Med Sci Monit In Press; DOI: 10.12659/MSM.940635  

25 May 2023 : Clinical Research  

Periapical Lesions and Missed Canals in Endodontically Treated Teeth: A Cone-Beam Computed Tomographic Stud...

Med Sci Monit In Press; DOI: 10.12659/MSM.940533  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750